BRUKER CORPORATION Current Income Tax Expense (Benefit)
BRUKER CORPORATION (BRKR) reported Current Income Tax Expense (Benefit) of $133.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-27
- BRUKER CORPORATION current income tax expense (benefit) for fiscal 2025 was $133.70M, a 13.85% decline from fiscal 2024.
- BRUKER CORPORATION current income tax expense (benefit) for fiscal 2024 was $155.20M, a 8.23% increase from fiscal 2023.
- BRUKER CORPORATION current income tax expense (benefit) for fiscal 2023 was $143.40M, a 12.56% increase from fiscal 2022.
- BRUKER CORPORATION current income tax expense (benefit) for fiscal 2022 was $127.40M, a 5.99% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $133.70M 10-K · filed 2026-02-27 |
| 2024-12-31 | $155.20M 10-K · filed 2026-02-27 |
| 2023-12-31 | $143.40M 10-K · filed 2026-02-27 |
| 2022-12-31 | $127.40M 10-K · filed 2025-03-03 |
| 2021-12-31 | $120.20M 10-K · filed 2024-02-29 |
| 2020-12-31 | $84.40M 10-K · filed 2023-03-01 |
| 2019-12-31 | $84.90M 10-K · filed 2022-02-28 |
| 2018-12-31 | $72.90M 10-K · filed 2021-03-01 |
| 2017-12-31 | $76.90M 10-K · filed 2020-03-27 |
| 2016-12-31 | $57.70M 10-K · filed 2019-03-01 |
| 2015-12-31 | $57.00M 10-K · filed 2018-03-16 |
| 2014-12-31 | $50.10M 10-K · filed 2017-03-01 |
| 2013-12-31 | $35.40M 10-K · filed 2016-02-29 |
| 2012-12-31 | $71.80M 10-K · filed 2015-02-27 |
| 2011-12-31 | $56.30M 10-K · filed 2014-02-27 |
| 2010-12-31 | $56.90M 10-K · filed 2013-02-28 |
| 2009-12-31 | $50.20M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |